Ravulizumab Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ravulizumab
P
- Pamine FQ (lactobacillus acidophilus / methscopolamine)
- Panglobulin (immune globulin intravenous)
- Panglobulin NF (immune globulin intravenous)
- Panzyga (immune globulin intravenous)
- Pediatrace (trace elements with selenium and iodide)
- Peditrace (trace elements)
- Pedte-Pak-4 (trace elements)
- Pedtrace-4 (trace elements)
- Phillips Colon Health (bifidobacterium infantis / lactobacillus acidophilus)
- phytase/zinc citrate
- Polygam S/D (immune globulin intravenous)
- ponesimod
- Ponvory (ponesimod)
- Primadophilus Bifidus (bifidobacterium infantis / lactobacillus acidophilus)
- Privigen (immune globulin intravenous)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Prodigen (bifidobacterium infantis / lactobacillus acidophilus)
- Prolia (denosumab)
- Provella (bifidobacterium infantis / lactobacillus acidophilus)
- Provenge (sipuleucel-T)
- PTE-4 (trace elements)
- PTE-5 (chromic chloride hexahydrate / copper sulfate / manganese sulfate / selenium / zinc sulfate)
- Pyzchiva (ustekinumab)
More about ravulizumab
- ravulizumab consumer information
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.